Fulgent Genetics, Inc. (FRA:7F0)
Germany flag Germany · Delayed Price · Currency is EUR
25.80
0.00 (0.00%)
At close: Nov 28, 2025

Fulgent Genetics Revenue

Fulgent Genetics had revenue of $84.07M USD in the quarter ending September 30, 2025, with 17.18% growth. This brings the company's revenue in the last twelve months to $315.55M, up 13.60% year-over-year. In the year 2024, Fulgent Genetics had annual revenue of $283.47M, down -1.99%.

Revenue (ttm)
$315.55M
Revenue Growth
+13.60%
P/S Ratio
2.82
Revenue / Employee
$240.33K
Employees
1,313
Market Cap
758.37M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024283.47M-5.74M-1.99%
Dec 31, 2023289.21M-329.76M-53.27%
Dec 31, 2022618.97M-373.62M-37.64%
Dec 31, 2021992.58M570.87M135.37%
Dec 31, 2020421.71M389.18M1,196.46%
Dec 31, 201932.53M11.18M52.35%
Dec 31, 201821.35M2.62M13.99%
Dec 31, 201718.73M454.00K2.48%
Dec 31, 201618.28M8.70M90.85%
Dec 31, 20159.58M8.30M649.30%
Dec 31, 20141.28M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition